Zacks Research Has Optimistic Outlook of PAHC Q2 Earnings

Phibro Animal Health Corporation (NASDAQ:PAHC) – Stock analysts at Zacks Research raised their Q2 2027 earnings estimates for shares of Phibro Animal Health in a report issued on Friday, September 18th. Zacks Research analyst Team now anticipates that the company will post earnings of $0.95 per share for the quarter, up from their previous forecast of $0.85. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for Phibro Animal Health’s current full-year earnings is $3.50 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2027 earnings at $0.82 EPS, Q4 2027 earnings at $0.90 EPS, FY2027 earnings at $3.46 EPS, Q1 2028 earnings at $0.83 EPS, Q2 2028 earnings at $1.01 EPS, Q3 2028 earnings at $0.90 EPS, Q4 2028 earnings at $0.92 EPS, FY2028 earnings at $3.65 EPS and FY2029 earnings at $3.87 EPS.

Separately, Weiss Ratings restated a “hold (c+)” rating on shares of Phibro Animal Health in a research note on Friday, September 11th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $47.67.

Phibro Animal Health Trading Up 1.4%

PAHC opened at $35.15 on Monday. The company has a fifty day moving average price of $35.64 and a two-hundred day moving average price of $40.33. Phibro Animal Health has a 1-year low of $28.25 and a 1-year high of $60.08. The company has a market cap of $1.43 billion, a P/E ratio of 14.41, a price-to-earnings-growth ratio of 1.00 and a beta of 0.46. The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.14. The business had revenue of $396.75 million for the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Wednesday, September 2nd will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, September 2nd. Phibro Animal Health’s dividend payout ratio (DPR) is currently 19.67%.

Institutional Trading of Phibro Animal Health

Hedge funds have recently bought and sold shares of the business. KBC Group NV bought a new position in shares of Phibro Animal Health in the first quarter valued at approximately $29,000. Rothschild Investment LLC boosted its position in shares of Phibro Animal Health by 2,500.0% during the fourth quarter. Rothschild Investment LLC now owns 1,040 shares of the company’s stock valued at $39,000 after buying an additional 1,000 shares during the last quarter. Inspire Investing LLC bought a new stake in Phibro Animal Health during the first quarter worth $158,000. Vestcor Inc bought a new stake in Phibro Animal Health during the fourth quarter worth $108,000. Finally, Sanctuary Advisors LLC purchased a new stake in Phibro Animal Health in the 1st quarter valued at $247,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation is a global animal-health and nutrition company that develops, manufactures and markets products intended to support the health, productivity and well-being of food-producing animals and companion animals. Its customers include livestock producers, veterinarians, feed manufacturers and distributors.

The company’s product portfolio includes vaccines, medicated feed additives, nutritional specialties, mineral and vitamin premixes, feed additives and other products used in poultry, swine, cattle, aquaculture and companion-animal applications.